Tag Archives: dementia

Survey highlights desire for involvement in Alzheimer’s trials, early detection

Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

Would you want to know if you were at risk of Alzheimer’s disease, although it’s incurable and treatment options are limited?

Most people said yes” according to a recent survey from the Alliance for Aging Research conducted by Avalere Health. The vast majority of those surveyed also said that early detection is important to them and that they are willing to participate in clinical trials. Continue reading

This is the brain on health disparities: Their role in dementia

Emily Willingham

About Emily Willingham

Emily Willingham (@ejwillingham) is AHCJ's core topic leader on the social determinants of health. She is a science journalist whose work has appeared in the Washington Post, San Francisco Chronicle, Wall Street Journal, Scientific American, and Forbes, among others, and co-author of "The Informed Parent: A Science-Based Guide to Your Child's First Four Years."

Photo: NIH Image Gallery via Flickr

In a recent commentary in JAMA Neurology, Elisa de Paula França Resende, M.D., of the University of California, San Francisco, and colleagues write about how social determinants of health affect demographic patterns of dementia in the United States. Noting that with an aging population, the prevalence of dementia will increase substantially, Resende and her co-authors write that of the social determinants affecting dementia risk, health and socioeconomics act more strongly than do race or cultural identifiers. I will add here that being female also is involved in dementia risk, as women are at greater risk for it than men. Continue reading

Panel examines improving quality of life for those with Alzheimer’s

Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

Photo: Pia Christensen/AHCJBrent P. Forester

While scientists are getting closer to understanding the various causes and risk factors for Alzheimer’s disease and dementias, there’s still no cure.

However, that doesn’t mean life is hopeless for millions of people who have the disease, or their families.  There’s a lot we can do improve their quality of life, according to panelists at a Health Journalism 2019 session on Alzheimer’s. Continue reading

Getting sources on the record when loved ones are involved

Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

Photo : Kelsey Kremer, Des Moines RegisterLinnea and Gailen Clausen share a moment outside the central Iowa nursing home where he lives, three hours away from their northwest Iowa home. Other nursing homes rejected Gailen Clausen, 55, because his early onset dementia caused confusion and anxiety, which sometimes led him to be aggressive toward staff.

Nursing homes are supposed to be places that care for ill, frail adults — many of whom also suffer from Alzheimer’s and other forms of dementia. The disease takes a terrible toll on those who have it, whether it’s forgetting who their loved ones are, forgetting how to eat or use the toilet, or sliding into a state of agitation and violence. That’s the time when more nursing homes are saying “enough.”

And, as Tony Leys writes in this article for the Des Moines Register last fall, they’re kicking them out, sometimes even if there’s nowhere else for them to go. Continue reading

Overprescribing of anti-dementia drugs comes at high cost

Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

Photo: Ian Iott via Flickr

There is no cure for dementia, a devastating group of diseases that eventually rob people of their memory, personality and quality of life. Only a few drugs are approved in the U.S. for short-term use to treat symptoms such as memory loss and confusion.  A recent analysis found that many patients remain on these drugs much longer than recommended, resulting in potential health risks and thousands of dollars in additional costs. Continue reading

New investment hopes to spur cure for dementia

Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

Photo: Liz SeegertActress Jane Krakowski, talking to Katie Couric, teared up as she spoke about her dad’s diagnosis of early onset dementia at age 61.

Alzheimer’s disease is the sixth leading cause of death in the U.S. Despite decades of research, there’s still no cure, and few options to slow or minimize symptoms. The last Alzheimer’s drug was approved more than 15 years ago, but a new campaign, called Disrupting Dementia, hopes to drive new diagnostics and treatments while also supporting patients and families affected by this devastating condition.

Continue reading